Impact Factor
4.64
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
20.97
5,645 total citations
h5-index
113
h5 depth signal
Cited share
70.1%
199 of 284
Total citations
5,645
Citation footprint
Metric signal
19.93
External metric anchor
Self-citation
1.0%
55 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
465
United Kingdom
208
Germany
124
Italy
99
Australia
92
Citing Fields of Research
Cardiology
1,118
Immunology
152
Diabetes
139
Lipids
136
Genetics & Genomics
84
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,403
Articles tracked across the journal lifetime
Indexed publication set
284
199 cited publications
Last 12 months
134
11.2 publications/month
Open access share
0.7%
1 OA publications in the last year
Leading citing country
United States
465 citing publications
Leading citing field
Cardiology
1,118 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v6,n4, Apr. 2009-
v6,n4, Apr. 2009-
Research Focus & Classification
Indexed Subjects
Cardiology
Issuing & Sponsoring Bodies
Contributor
World Heart Federation
Broad Categories
Cardiology
MeSH Descriptors
Cardiovascular Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41569-026-01360-1
Open DOI
Duration of antibiotic treatment for infective endocarditis: should we move towards tailored therapy?
02
DOI 10.1038/s41569-026-01356-x
Open DOI
Heart-specific T cell responses: from antigens to disease mechanisms
The field of immunology has transformed our understanding of myocardial cell biology and paved the way for new pathophysiological concepts in cardiology. Researchers have sought to elucidate the contributions of nonspecific inflammatory ...
03
DOI 10.1038/s41569-026-01357-w
Open DOI
Beyond glucose lowering and ketogenesis: unveiling new cardioprotective mechanisms of SGLT2 inhibitors
04
DOI 10.1038/s41569-026-01334-3
Open DOI
Global burden of venous thromboembolism: incidence and outcome estimates of deep-vein thrombosis and pulmonary embolism
Venous thromboembolism (VTE), including deep-vein thrombosis and pulmonary embolism, is the third most common cause of vascular death worldwide and a major contributor to costly and debilitating non-fatal complications. Despite the chang...
05
DOI 10.1038/s41569-026-01355-y
Open DOI
Beating the odds: bringing the human heart into a dish
06
DOI 10.1038/s41569-026-01353-0
Open DOI
Benefit of aficamten in non-obstructive hypertrophic cardiomyopathy
07
DOI 10.1038/s41569-026-01350-3
Open DOI
Pulmonary artery denervation shows promising results for heart failure-related pulmonary hypertension
08
DOI 10.1038/s41569-026-01351-2
Open DOI
Tricuspid valve repair reduces death and HF hospitalization
09
DOI 10.1038/s41569-026-01352-1
Open DOI
High-altitude hypoxia and congenital heart defects
10
DOI 10.1038/s41569-026-01349-w
Open DOI
Genetic cardiomyopathy-associated myocarditis
Bibliographical & Catalog Notes
Description based on: Vol. 6, no. 4 (Apr. 2009); title from cover.
Latest issue consulted: Vol. 6, no. 4 (Apr. 2009).
Also issued online.